Stay informed with the latest litigation news. Explore now

IP Verse

Actelion Pharmaceuticals competitive analysis

Latest publications and patents of Actelion Pharmaceuticals New

Explore the latest publications and patents granted to Actelion Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 2, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Actelion Pharmaceuticals

EP4065119
Sep 4, 2024Methods Of Treating Pulmonary Arterial HypertensionGranted And Under Opposition
EP3897646
May 22, 2024Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionGranted And Under Opposition
EP3256125
Jan 26, 2022Dosing Regimen For A Selective S1P1 Receptor AgonistGranted And Under Opposition
EP3592391
Apr 21, 2021Pharmaceutical Composition Comprising SelexipagGranted And Under Opposition
EP3300729
Oct 9, 2019Therapeutic Compositions Containing MacitentanRevoked
EP3071578
Jan 10, 2018Tricyclic Piperidine CompoundsNo Opposition Filed Within Time Limit
EP3044211
Jan 3, 2018Antibacterial 2H-Indazole DerivativesNo Opposition Filed Within Time Limit
EP2315587
Oct 25, 2017Therapeutic Compositions Containing MacitentanRevoked

Latest patents of Actelion Pharmaceuticals opposed by its competitors

Explore Actelion Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4065119
Sep 4, 2024Methods Of Treating Pulmonary Arterial Hypertension4
EP3897646
May 22, 2024Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension3
EP3256125
Jan 26, 2022Dosing Regimen For A Selective S1P1 Receptor Agonist2
EP3592391
Apr 21, 2021Pharmaceutical Composition Comprising Selexipag1
EP3300729
Oct 9, 2019Therapeutic Compositions Containing Macitentan3
EP2315587
Oct 25, 2017Therapeutic Compositions Containing Macitentan5

Latest PTAB cases involving Actelion Pharmaceuticals New

Discover the latest PTAB cases involving Actelion Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 8, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Actelion Pharmaceuticals

IPR2025-01139Jun 10, 2025UNITED THERAPEUTICSACTELION PHARMACEUTICALSPending
IPR2015-00562Jan 13, 2015ACTELION PHARMACEUTICALSICOSFinal Written Decision
IPR2015-00561Jan 13, 2015ACTELION PHARMACEUTICALSICOSFinal Written Decision

Top competitors of Actelion Pharmaceuticals

Top competitors of Actelion Pharmaceuticals based on patent oppositions.